|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of deferred contract costs | |||||
| Stock-based compensation | |||||
| Allowance for credit losses | |||||
| Net (accretion) amortization of marketable securities | |||||
| Non-cash operating lease expense | |||||
| Unrealized loss on strategic investments | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other assets | |||||
| Deferred contract costs | |||||
| Accounts payable, accrued expenses and other liabilities | |||||
| Content costs payable | |||||
| Operating lease liabilities | |||||
| Deferred revenue | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of marketable securities | |||||
| Proceeds from maturities and sales of marketable securities | |||||
| Purchases of property and equipment | |||||
| Capitalized software costs | |||||
| Purchases of strategic investments | |||||
| Payments related to asset acquisitions | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Net proceeds from exercise of stock options | |||||
| Proceeds from share purchases under employee stock purchase plan | |||||
| Payment of redeemable convertible preferred stock issuance costs | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Net proceeds from issuance of redeemable convertible preferred stock | |||||
| Repurchases of common stock and excise taxes paid | |||||
| Payment of deferred offering costs | |||||
| Cash proceeds from initial public offering | |||||
| Payments of debt issuance costs | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of foreign exchange rates on cash flows | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash—Beginning of period | |||||
| Cash, cash equivalents and restricted cash—End of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Net change in unrealized gain (loss) on marketable securities | |||||
| Unpaid deferred offering costs | |||||
| Acquisition holdback liability | |||||
| Increase (decrease) in purchases of property and equipment included in liabilities | |||||
| Operating lease right-of-use assets exchanged for operating lease liabilities | |||||
| Accrued excise tax on share repurchases | |||||
| Reconciliation of cash, cash equivalents and restricted cash: | |||||
| Cash and cash equivalents | |||||
| Restricted cash, current | |||||
| Restricted cash, non-current | |||||
Loading...